ino-3107
ino-3107: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | Phase 1/Phase 2 |
FDA Decisions
FDA_MeetingCompany plans to request a meeting with FDA to discuss next steps to remain eligible under the accelerated approval program.(INO)
Frequently asked questions
Who is developing ino-3107?
ino-3107 is being developed by INOVIO PHARMACEUTICALS, INC..
What is ino-3107's latest FDA decision?
The most recent tracked FDA decision for ino-3107 is FDA_Meeting for Company plans to request a meeting with FDA to discuss next steps to remain eligible under the accelerated approval program..
Get deeper analysis on ino-3107
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis